ESMO Gynaecological Cancers Congress

The scientific programme will feature keynote lectures, panel discussions, and interactive sessions covering a range of topics, including practice-changing treatments, recent developments in therapies integrating PARP inhibitors, targeted agents, and antibody-drug conjugates (ADCs) for managing ovarian cancer, as well as state-of-the-art approaches in the diagnosis and management of cervical and endometrial cancers. 

The congress will also provide opportunities for young specialists to present their research and engage with leaders in the field, promoting mentorship and the exchange of ideas. 

Latest Features